Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera. Veröffentlicht vonbrigittemeiswinkel 9. November 2020 Wagner, SM; Melchardt, T; Greil, R. DRUG TODAY. 2020; 56(3): 195-202. https://pubmed.ncbi.nlm.nih.gov/32282866/